TREA

79366678 - BIFICOL

Follow

Information

  • Trademark
  • 79366678
  • Serial Number
    79366678
  • Registration Number
    7518277
  • Filing Date
    February 17, 2023
    a year ago
  • Registration Date
    October 01, 2024
    4 months ago
  • Transaction Date
    January 01, 2025
    a month ago
  • Status Date
    October 01, 2024
    4 months ago
  • Published for Opposition Date
    July 16, 2024
    7 months ago
  • Location Date
    September 30, 2024
    4 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    O'BRIEN, JENNIFER
  • Attorney Docket Number
    MARB-69577
    Attorney Name
    Michelle E. Tochtrop
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BIFICOL
Case File Statements
  • GS0051: Micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings and to reared animal species, for medical and veterinary use; micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, probiotic bifidobacterium bacteria capable of inducing a metabolic action able to affect cholesterol levels in blood; specialty pharmaceuticals containing micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, probiotic bifidobacterium bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora such as diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, in the form of pharmaceuticals for oral application, in particular capsules, compress, solutions, suspensions, granules, granulates in dried or freeze-dried form, food supplements, food supplements for medical use containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings; dietary supplements; food supplements containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings, not for medical use; symbiotic dietary supplements containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria and prebiotic fibres
  • GS0011: Micro-organisms and cultures of micro-organisms, in particular bacteria for use in food manufacture, bifidobacterium probiotic bacteria for use in the manufacture of food supplements, food, cosmetics, yeast nutrients for industrial purposes and fermented milk products in the nature of milk ferments for industrial purposes; micro-organisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacterium bacteria to be administered to human beings and reared animal species, not for medical or veterinary use for use in the manufacture of food supplements, food, cosmetics; micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form, namely, probiotic bacteria for use in the manufacture of food supplements, food, cosmetics
Case File Event Statements
  • 12/7/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 12/7/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/31/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC
  • 4/3/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/7/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/16/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/6/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/7/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/5/2024 - 8 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/5/2024 - 8 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/5/2024 - 8 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/10/2024 - 8 months ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/2/2024 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/10/2024 - 8 months ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/11/2024 - 8 months ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/10/2024 - 8 months ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/10/2024 - 8 months ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/26/2024 - 7 months ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/16/2024 - 7 months ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/16/2024 - 7 months ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/16/2024 - 7 months ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/28/2024 - 5 months ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 8/28/2024 - 5 months ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/14/2024 - 5 months ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 10/1/2024 - 4 months ago
    27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 1/1/2025 - a month ago
    28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 7/16/2024 - 7 months ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/1/2024 - 4 months ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR